Dominantly inherited Alzheimer's disease in Latin America: Genetic heterogeneity and clinical phenotypes

Abstract

Future DIAD studies will be required in LatAm, albeit with a more systematic approach to include fluid biomarker and imaging studies. Regional efforts are under way to extend the DIAD observational studies and clinical trials to Latin America.